Biomedical
Research
Research
Who we are
Supporting scientific discovery
Consistency and reliability are paramount in scientific research. Our proprietary purification platform ensures an exceptional exosome purity exceeding 90%, with an average particle size of exactly 101.1 nanometers and a dense concentration of over 10 billion particles per milliliter.
Furthermore, our materials undergo rigorous third-party testing following OECD guidelines, confirming absolutely zero cytotoxicity, skin irritation (OECD 439), eye irritation (OECD 492), or genotoxicity (OECD 471).
This provides your laboratory with a highly stable, cell-free foundation for reproducible and uncontaminated experimental results
Clinical Solutions
Our Scientific Approach
Our work is designed to engage with laboratories, research institutions, and product development organizations operating in regulated research environments.
Research Domains
- Cellular and molecular research
- Advanced biological systems
- Pre-commercial scientific exploration
Who we are
RMD Bioscience Competitive Advantage
Transitioning to exosome-based research models offers significant advantages over traditional stem cell or Platelet-Rich Plasma (PRP) methodologies.
Our cell-free exosome products eliminate the complexities, high costs, and immune rejection risks associated with live cell cultures, while offering a much richer, standardized profile of signaling molecules than plant-derived alternatives.